This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Albemarle (ALB) Launches XPLORE & First Grade KF 787 PULSAR
by Zacks Equity Research
Albemarle (ALB) is committed to innovation in the market through KF 787 PULSAR and the XPLORE platform technology.
Albemarle (ALB) Q3 Earnings Top Estimates, Revenues Lag
by Anindya Barman
Higher lithium prices and gains across Bromine Specialties and Catalysts units drove Albemarle's (ALB) Q3 earnings.
Albemarle (ALB) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 4.80% and -3.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Can Albemarle (ALB) Beat Earnings in Q3 on Lithium Strength?
by Anindya Barman
Albemarle (ALB) is likely to gain from favorable pricing and volume trends in its Lithium segment in Q3.
Albemarle (ALB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $106.44, marking a +0.97% move from the previous day.
Albemarle (ALB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allegheny Technologies (ATI) Q3 Earnings: A Beat in Store?
by Zacks Equity Research
Allegheny's (ATI) FRP unit is likely to benefit from operational improvements and strong end-market demand.
Will Strong Demand Aid Cleveland-Cliffs' (CLF) Q3 Earnings?
by Zacks Equity Research
Cleveland-Cliffs' (CLF) Q3 results to benefit from strong demand for pellets.
Can Albemarle (ALB) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Albemarle (ALB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is a Beat in the Cards for Celanese (CE) in Q3 Earnings?
by Zacks Equity Research
Celanese's (CE) strategic measures including cost savings through productivity actions and efficiency enhancement are expected to drive third-quarter earnings.
Will Higher Costs Dent PPG Industries' (PPG) Q3 Earnings?
by Anindya Barman
PPG Industries (PPG) faces cost pressure associated with raw materials and logistics that is likely to hurt its margins in Q3.
Cal-Maine Foods to Acquire Assets of Featherland Egg Farms
by Zacks Equity Research
Cal-Maine Foods (CALM) inks deal to acquire the egg production, processing, sales and distribution business of Featherland Egg Farms.
5 Chemical Stocks That Are Poised for Solid Upside in Q4
by Anindya Barman
As the chemical industry's upturn is likely to continue in Q4, it would be prudent to zero in on these chemical stocks that have compelling prospects.
Why Should You Add Celanese (CE) to Your Portfolio Now?
by Anindya Barman
Strong fundamentals and compelling growth prospects make Celanese (CE) an attractive choice for investment.
5 Reasons to Add Eastman Chemical (EMN) to Your Portfolio
by Anindya Barman
Based on its compelling prospects, we believe Eastman Chemical (EMN) has plenty of upside potential.
Top Ranked Momentum Stocks to Buy for October 2nd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 2nd:
Valvoline (VVV) Unit Opens VIOC Service Center in Uniondale
by Zacks Equity Research
Valvoline's (VVV) instant oil change service centers provide services like tire rotation, preventive maintenance services and replacement of safety parts.
5 Reasons to Add Albemarle (ALB) Stock to Your Portfolio Now
by Anindya Barman
Strong fundamentals and compelling growth prospects make Albemarle (ALB) an attractive choice for investment.
US Shale-Linked Chemical Spending Hits $200B: 5 Stocks to Buy
by Anindya Barman
The U.S. chemical industry is in the middle of a shale-induced investment boom leveraging access to abundant and cheap feedstocks.
Why Is Albemarle (ALB) Down 2.4% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle (ALB) Looks Good: Stock Adds 6.4% in Session
by Zacks Equity Research
Albemarle (ALB) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Albemarle (ALB) Tops Q2 Earnings Estimates, Raises FY18 View
by Anindya Barman
Albemarle (ALB) raised its adjusted earnings outlook for 2018 to $5.30-$5.50 per share.
Albemarle (ALB) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 6.25% and 6.80%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Earnings to Watch on Aug 7: ALB, IFF, VSM
by Anindya Barman
Chemical companies are likely to gain from strategic actions and a favorable demand environment.
Can Lithium Help Albemarle (ALB) Beat Earnings Again in Q2?
by Anindya Barman
While Albemarle (ALB) faces certain headwinds in its Bromine and Catalysts businesses, it should gain from strength in its Lithium unit.